ArticleTherapeutic advances in musculoskeletal disease2026
Incidence of interstitial lung disease in seropositive rheumatoid arthritis patients receiving biologics, Janus kinase inhibitors, or methotrexate.
Jiyeol Yoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.